Israel’s CardiacSense has received the European CE Mark for its medical-grade wristwatch that continually measures heart rate and arrhythmias. It is the first time an official regulator has approved such a device. CardiacSense has distribution agreements worth some $100 million.

https://www.cardiacsense.com/news/cardiacsense-medical-grade-watch-receives-ce-mark-for-continuous-detection-of-atrial-fibrillation/

https://www.calcalistech.com/ctech/articles/0,7340,L-3892750,00.html